Asia Pacific Nasal Irrigation Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Manual Nasal Irrigators, Electric Nasal Irrigators, and Battery-Powered Nasal Irrigators), Patient Type (Pediatrics and Adult), Applic

Asia Pacific Nasal Irrigation Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Manual Nasal Irrigators, Electric Nasal Irrigators, and Battery-Powered Nasal Irrigators), Patient Type (Pediatrics and Adult), Application (Rhinitis, Sinus, Bronchiolitis, Post-Operative Respiratory Conditions, and Others), and End User (Hospitals & Clinics, Home Care, and Others)

The Asia Pacific nasal irrigation devices market is expected to grow from US$ 73.10 million in 2022 to US$ 205.93 million by 2028; it is estimated to record a CAGR of 18.8% from 2022 to 2028.

Cumulative Awareness Among Patients and Benefits Offered by Nasal Irrigation Bolster the Asia Pacific Nasal Irrigation Devices Market Growth

Nasal irrigation is the practice of upper respiratory tract care, originated from traditional ayurvedic medicine. It was later adopted by western medicine and gained popularity across the world. Nasal irrigation therapy is combined with other therapies for improved efficiency and speedy recovery. It is one of the most common methods used to relieve the congestion of nasal passage and treat various nasal infections caused by pollution, allergies, and pollens. The increasing prevalence of nasal allergies and sinus infections has created a demand for nasal irrigation. Nasal irrigation aids in washing allergens away, pulling out fluids, improving breathing, clearing sinuses passage, and so on. Of late, the awareness regarding these benefits has increased among consumers in Asia Pacific, translating into high demand for nasal irrigation devices.

Asia Pacific Nasal Irrigation Devices Market Overview

The Asia Pacific nasal irrigation devices market is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. According to Allergy, Asthma, & Immunology Research, 2019, allergic rhinitis is a major health, medical, and economic problem in China, and it primarily affects children. China is one of the largest countries in the world with ~1.4 billion citizens, and it has different topographic, climatic, and economic conditions, which influence people’s lifestyles along with exposing them to different allergens. Thus, the growth of the nasal irrigation devices market in China is attributed to the growing incidence of respiratory illnesses and increasing developments by domestic market players.

Asia Pacific Nasal irrigation devices Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Nasal irrigation devices Market Segmentation

The Asia Pacific nasal irrigation devices market is segmented on the basis of product type, patient type, application, end user, and country. Based on product type, the Asia Pacific nasal irrigation devices market is segmented into manual nasal irrigators, electric nasal irrigators, and battery-powered nasal irrigators. The manual nasal irrigators segment held the largest market share in 2022.

Based on patient type, the Asia Pacific nasal irrigation devices market is bifurcated into pediatrics and adult. The adult segment held a larger market share in 2022.

Based on application, the Asia Pacific nasal irrigation devices market is segmented into rhinitis, sinus, bronchiolitis, post-operative respiratory conditions, and others. The sinus segment held the largest market share in 2022.

Based on end user, the Asia Pacific nasal irrigation devices market is segmented into hospitals & clinics, home care, and others. The home care segment held the largest market share in 2022.

Based on country, the Asia Pacific nasal irrigation devices market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the market share in 2022.

Air Liquide Medical Systems; Neilmed Pharmaceuticals Inc.; Stryker Corp; Heal Force; Bremed Ltd.; Medtronic Plc; and Bayer AG are among the leading companies operating in the Asia Pacific nasal irrigation devices market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific nasal irrigation devices market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific nasal irrigation devices market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific nasal irrigation devices market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution